Purple Biotech Ltd. (PPBT.TA)
ILA 6.9
(-4.17%)
ILA 6.9
(-4.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -22.22 Million USD | 99.9% |
| 2022 | -21.43 Million USD | -23.3% |
| 2021 | -17.38 Million USD | 37.83% |
| 2020 | -28.41 Million USD | -266.06% |
| 2019 | -7.63 Million USD | 1.14% |
| 2018 | -7.72 Million USD | 35.23% |
| 2017 | -11.92 Million USD | -69.37% |
| 2016 | -7.04 Million USD | -67.77% |
| 2015 | -4.19 Million USD | 19.75% |
| 2014 | -5.23 Million USD | -337.01% |
| 2013 | -1.19 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.71 Million USD | 25.35% |
| 2024 Q2 | -3.08 Million USD | 36.98% |
| 2023 Q4 | -4.97 Million USD | 0.22% |
| 2023 FY | - USD | 99.9% |
| 2023 Q1 | -4.79 Million USD | 19.7% |
| 2023 Q2 | -4.95 Million USD | -3.36% |
| 2023 Q3 | -4.98 Million USD | -0.6% |
| 2022 Q3 | -4.78 Million USD | -38.74% |
| 2022 Q4 | -5.97 Million USD | -24.87% |
| 2022 FY | - USD | -23.3% |
| 2022 Q1 | -7.22 Million USD | -59.51% |
| 2022 Q2 | -3.44 Million USD | 52.26% |
| 2021 Q4 | -4.52 Million USD | -47.77% |
| 2021 Q1 | -6.5 Million USD | -42.33% |
| 2021 Q3 | -3.06 Million USD | 12.0% |
| 2021 FY | - USD | 37.83% |
| 2021 Q2 | -3.48 Million USD | 46.48% |
| 2020 Q4 | -4.57 Million USD | -9.43% |
| 2020 Q3 | -4.17 Million USD | -98.5% |
| 2020 Q2 | -2.1 Million USD | 0.0% |
| 2020 Q1 | -2.1 Million USD | -111.56% |
| 2020 FY | - USD | -266.06% |
| 2019 Q4 | -995 Thousand USD | 36.89% |
| 2019 Q2 | -1.73 Million USD | 0.0% |
| 2019 Q1 | -1.73 Million USD | -24.3% |
| 2019 FY | - USD | 1.14% |
| 2019 Q3 | -1.57 Million USD | 9.08% |
| 2018 Q4 | -1.39 Million USD | 0.0% |
| 2018 FY | - USD | 35.23% |
| 2018 Q3 | -1.39 Million USD | 46.68% |
| 2018 Q2 | -2.61 Million USD | 0.0% |
| 2018 Q1 | -2.61 Million USD | -4.02% |
| 2017 Q3 | -2.51 Million USD | 0.14% |
| 2017 FY | - USD | -69.37% |
| 2017 Q4 | -2.51 Million USD | 0.0% |
| 2017 Q1 | -2.51 Million USD | -27.87% |
| 2017 Q2 | -2.51 Million USD | 0.0% |
| 2016 Q2 | -1.57 Million USD | 0.0% |
| 2016 Q4 | -1.97 Million USD | 0.0% |
| 2016 FY | - USD | -67.77% |
| 2016 Q1 | -1.57 Million USD | 5.48% |
| 2016 Q3 | -1.97 Million USD | -24.8% |
| 2015 FY | - USD | 19.75% |
| 2015 Q4 | -1.67 Million USD | -85.14% |
| 2015 Q3 | -902 Thousand USD | -2019.15% |
| 2015 Q2 | 47 Thousand USD | 146.08% |
| 2015 Q1 | -102 Thousand USD | 94.06% |
| 2014 Q3 | -1.11 Million USD | -8661.54% |
| 2014 Q4 | -1.71 Million USD | -54.18% |
| 2014 Q2 | 13 Thousand USD | 101.59% |
| 2014 FY | - USD | -337.01% |
| 2014 Q1 | -818 Thousand USD | -4995.94% |
| 2013 Q2 | 22.94 Thousand USD | -80.48% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | -16.05 Thousand USD | 95.14% |
| 2013 Q3 | -330.34 Thousand USD | -1539.8% |
| 2013 Q1 | 117.55 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Matricelf Ltd | -11.51 Million ILA | -93.059% |